Warm autoimmune hemolytic anemia is a chronic, relapsing disease characterized by anemia, reticulocytosis, other evidence of hemolysis, and a positive direct antiglobulin test. First-line therapy (after prompt transfusion of ABO- and RhD-matched blood in patients with severe anemia) involves glucocorticoids and rituximab.
No takes yet. Share an insight, caveat, or question.
Robert A. Brodsky (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: